Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy

被引:127
作者
Xylinas, Evanguelos [1 ,5 ]
Rink, Michael [1 ,7 ]
Margulis, Vitaly [2 ]
Clozel, Thomas [1 ]
Lee, Richard K. [1 ]
Comploj, Evi [8 ]
Novara, Giacomo [9 ]
Raman, Jay D. [3 ]
Lotan, Yair [2 ]
Weizer, Alon [4 ]
Roupret, Morgan [1 ,6 ]
Pycha, Armin [8 ]
Scherr, Douglas S. [1 ]
Seitz, Christian [11 ]
Ficarra, Vincenzo [9 ]
Quoc-Dien Trinh [12 ]
Karakiewicz, Pierre I. [12 ]
Montorsi, Francesco [10 ]
Zerbib, Marc [5 ]
Shariat, Shahrokh F. [1 ]
机构
[1] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Urol, Div Med Oncol SFS, New York, NY 10065 USA
[2] Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA
[3] Penn State Milton S Hershey Med Ctr, Div Urol, Hershey, PA USA
[4] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA
[5] Paris Descartes Univ, Dept Urol, Cochin Hosp, APHP, Paris, France
[6] Grp Hosp Pitie Salpetriere, AP HP, Dept Urol, Fac Med Pierre & Marie Curie, F-75634 Paris, France
[7] Univ Med Ctr Hamburg Eppendorf, Dept Urol, Hamburg, Germany
[8] Gen Hosp Bolzano, Dept Urol, Bolzano, Italy
[9] Univ Padua, Dept Urol, Padua, Italy
[10] Univ Vita Salute San Raffaele, Dept Urol, Milan, Italy
[11] Med Univ Vienna, Dept Urol, St John God Hosp, Teaching Hosp, Vienna, Austria
[12] Univ Montreal, Dept Urol, Montreal, PQ, Canada
关键词
renal function; radical nephroureterectomy; upper tract urothelial carcinoma; chemotherapy; TRACT UROTHELIAL CARCINOMA; CHRONIC KIDNEY-DISEASE; OUTCOMES; NEPHROURETERECTOMY; PROGNOSIS; SURGERY;
D O I
10.1111/j.1464-410X.2012.11649.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective To report (i) the estimated glomerular filtration rate (eGFR) changes in patients undergoing radical nephro-ureterectomy (RNU) for upper tract urothelial carcinoma (UTUC); (ii) the rate of change in eGFR in patients eligible for cisplatin-based chemotherapy; and (iii) the association of preoperative, postoperative and rate of change of renal function variables with survival outcomes. Patient and Methods We performed a retrospective analysis of 666 patients treated with RNU for UTUC at seven international institutions from 1994 to 2007. The eGFR was calculated at baseline and at 3-6 months (Modification of Diet in Renal Disease formula (MDRD) and Chronic Kidney Disease Epidemiology Collaboration formula (CKD-EP) equations). Results The median (interquartile range) eGFR decreased by 18.2 (8-12)% after RNU. A total of 37% of patients had a preoperative eGFR 60mL/min/1.73m(2), which decreased to 16% after RNU (P < 0.001); 72% of patients had a preoperative eGFR 45mL/min/1.73m(2), which decreased to 52% after RNU (P < 0.001). The distributions were similar when analyses were restricted to patients with locally advanced disease (pT3-pT4) and/or lymph node metastasis. Patients older than the median age of 70 years were more likely to have a decrease in eGFR after RNU (P < 0.001). None of the renal function variables was associated with clinical outcomes such as disease recurrence, cancer-specific and overall mortality; however, when analyses were restricted to patients who had no adjuvant chemotherapy and did not experience disease recurrence (n = 431), a preoperative eGFR 60mL/min/1.73m(2) (P = 0.03) and a postoperative eGFR 45mL/min/1.73m(2) (P = 0.04) were associated with better overall survival in univariable analyses. Conclusions In patients who had UTUC, eGFR was low and furthermore, it significantly decreased after RNU. Renal function did not affect cancer-specific outcomes after RNU.
引用
收藏
页码:453 / 461
页数:9
相关论文
共 30 条
[1]   Neoadjuvant chemotherapy in invasive bladder cancer:: Update of a systematic review and meta-analysis of individual patient data [J].
Abol-Enein, H ;
Bassi, P ;
Boyer, M ;
Coppin, CML ;
Cortesi, E ;
Grossman, HB ;
Hall, RR ;
Horwich, A ;
Malmström, PU ;
Martinez-Piñeiro, JA ;
Sengelov, L ;
Sherif, A ;
Wallace, DMA ;
Bono, AV ;
Goebell, PJ ;
Groshen, S ;
Torti, FM ;
Clarke, NW ;
Roberts, JT ;
Sylvester, R ;
Parmar, MKB ;
Stewart, LA ;
Tierney, JF ;
Vale, CL .
EUROPEAN UROLOGY, 2005, 48 (02) :202-206
[2]   Troubling Outcomes From Population-level Analysis of Surgery for Upper Tract Urothelial Carcinoma [J].
Abouassaly, Robert ;
Alibhai, Shabbir M. H. ;
Shah, Nasir ;
Timilshina, Narhari ;
Fleshner, Neil ;
Finelli, Antonio .
UROLOGY, 2010, 76 (04) :895-901
[3]  
[Anonymous], 2002, AJCC CANC STAGING HD
[4]   Adjuvant chemotherapy in invasive bladder cancer: A systematic review and meta-analysis of individual patient data [J].
Bono, AV ;
Goebell, PJ ;
Groshen, S ;
Lehmann, J ;
Studer, U ;
Torti, FM ;
Abol-Enein, H ;
Bassi, P ;
Boyer, M ;
Coppin, CML ;
Cortesi, E ;
Hall, RR ;
Horwich, A ;
Malmström, PU ;
Martínez-Piñeiro, JA ;
Sengelov, L ;
Sherif, A ;
Wallace, DMA ;
Clarke, NW ;
Roberts, JT ;
Sylvester, R ;
Parmar, MKB ;
Stewart, LA ;
Tierney, JF ;
Vale, CL .
EUROPEAN UROLOGY, 2005, 48 (02) :189-201
[5]   CKD Surveillance Using Laboratory Data From the Population-Based National Health and Nutrition Examination Survey (NHANES) [J].
Castro, Alejandro F. ;
Coresh, Josef .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 53 (03) :S46-S55
[6]   The Impact of Tumor Multifocality on Outcomes in Patients Treated With Radical Nephroureterectomy [J].
Chromecki, Thomas F. ;
Cha, Eugene K. ;
Fajkovic, Harun ;
Margulis, Vitaly ;
Novara, Giacomo ;
Scherr, Douglas S. ;
Lotan, Yair ;
Raman, Jay D. ;
Kassouf, Wassim ;
Bensalah, Karim ;
Weizer, Alon ;
Kikuchi, Eiji ;
Roscigno, Marco ;
Remzi, Mesut ;
Matsumoto, Kazumasa ;
Walton, Thomas J. ;
Pycha, Armin ;
Ficarra, Vincenzo ;
Karakiewicz, Pierre I. ;
Zigeuner, Richard ;
Pummer, Karl ;
Shariat, Shahrokh F. .
EUROPEAN UROLOGY, 2012, 61 (02) :245-253
[7]   Prognostic factors for upper urinary tract urothelial carcinoma [J].
Chromecki, Thomas F. ;
Bensalah, Karim ;
Remzi, Mesut ;
Verhoest, Gregory ;
Cha, Eugene K. ;
Scherr, Douglas S. ;
Novara, Giacomo ;
Karakiewicz, Pierre I. ;
Shariat, Shahrokh F. .
NATURE REVIEWS UROLOGY, 2011, 8 (08) :440-447
[8]   The World Health Organization International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder [J].
Epstein, JI ;
Amin, MB ;
Reuter, VR ;
Mostofi, FK .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1998, 22 (12) :1435-1448
[9]   Adjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma: Results From the Upper Tract Urothelial Carcinoma Collaboration [J].
Hellenthal, Nicholas J. ;
Shariat, Shahrokh F. ;
Margulis, Vitaly ;
Karakiewicz, Pierre I. ;
Roscigno, Marco ;
Bolenz, Christian ;
Remzi, Mesut ;
Weizer, Alon ;
Zigeuner, Richard ;
Bensalah, Karim ;
Ng, Casey K. ;
Raman, Jay D. ;
Kikuchi, Eiji ;
Montorsi, Francesco ;
Oya, Mototsugu ;
Wood, Christopher G. ;
Fernandez, Mario ;
Evans, Christopher P. ;
Koppie, Theresa M. .
JOURNAL OF UROLOGY, 2009, 182 (03) :900-906
[10]   Changes in Renal Function Following Nephroureterectomy May Affect the Use of Perioperative Chemotherapy [J].
Kaag, Matthew G. ;
O'Malley, Rebecca L. ;
O'Malley, Padraic ;
Godoy, Guilherme ;
Chen, Mang ;
Smaldone, Marc C. ;
Hrebinko, Ronald L. ;
Raman, Jay D. ;
Bochner, Bernard ;
Dalbagni, Guido ;
Stifelman, Michael D. ;
Taneja, Samir S. ;
Huang, William C. .
EUROPEAN UROLOGY, 2010, 58 (04) :581-587